New York University
New York, New York, United States
As a neuropathologist at NYU Langone, Dr. Snudderl diagnoses brain tumors and other brain diseases in children and adults. As director of molecular pathology, he oversee molecular and genomic profiling, a laboratory method that allows the team to accurately diagnose all types of brain tumors.
His clinical research focuses on identifying novel biomarkers for diagnosis and therapy. His laboratory at NYU Langone studies cancer genetics and epigenetics and examines the molecular differences between tumors at the cellular level.
His team discovered several novel molecularly defined subtypes of brain tumors and contributed to the development of DNA methylation–based classification of brain tumors, an approach that uses machine learning and epigenetic signatures to more effectively diagnose brain tumors. His laboratory is the first in the United States to provide this test to people with brain tumors.
He is a member of several professional societies, including the American Association for the Advancement of Science and the American Association of Neuropathologists. He also received the Lucien Rubinstein Award for my research in neuro-oncology.
